positive
5 days agoBiotech firm BillionToOne raises $273 m in U.S. IPO amid market rebound

On 6 November 2025, U.S.-based molecular diagnostics company BillionToOne raised $273.1 million in its initial public offering, pricing at $60 per share, above its previously marketed range of $49–$55. The listing values the company at about $2.64 billion and comes as the U.S. IPO market shows signs of revival after a lull. Market watchers view the deal as a potential lead for other life-sciences companies considering public listings.
positive
5 days agoBiotech firm BillionToOne raises $273 m in U.S. IPO amid market rebound

On 6 November 2025, U.S.-based molecular diagnostics company BillionToOne raised $273.1 million in its initial public offering, pricing at $60 per share, above its previously marketed range of $49–$55. The listing values the company at about $2.64 billion and comes as the U.S. IPO market shows signs of revival after a lull. Market watchers view the deal as a potential lead for other life-sciences companies considering public listings.
5 days ago
1 min read
68 words

BillionToOne raised $273 m in a U.S. IPO at $60/share, signalling early signs of a biotech listing revival.
On 6 November 2025, U.S.-based molecular diagnostics company BillionToOne raised $273.1 million in its initial public offering, pricing at $60 per share, above its previously marketed range of $49–$55. The listing values the company at about $2.64 billion and comes as the U.S. IPO market shows signs of revival after a lull. Market watchers view the deal as a potential lead for other life-sciences companies considering public listings.

On 6 November 2025, U.S.-based molecular diagnostics company BillionToOne raised $273.1 million in its initial public offering, pricing at $60 per share, above its previously marketed range of $49–$55. The listing values the company at about $2.64 billion and comes as the U.S. IPO market shows signs of revival after a lull. Market watchers view the deal as a potential lead for other life-sciences companies considering public listings.
Companies:
BillionToOne
Tags:
ipo
stocks
ipo
stocks
global
biotech
USA
Nov 6, 2025 • 18:21 IST